Valeant Pharmaceuticals International Inc (NYSE:VRX)

202.61
Delayed Data
As of Mar 03
 -0.74 / -0.36%
Today’s Change
106.00
Today|||52-Week Range
204.66
+41.58%
Year-to-Date

Today’s Trading

Previous close203.35
Today’s open201.45
Day’s range-- - --
Volume3,441,033
Average volume (3 months)2,716,888
Market cap$67.8B
Dividend yield--
Data as of 03/03/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+25.40%
Earnings growth (next 5 years)+25.10%
Revenue growth (last year)+43.22%
P/E ratio75.7
Price/Sales5.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGNAllergan-0.94-0.40%
ABTAbbott Laboratories-0.13-0.28%
LLYEli Lilly and Co-0.75-1.05%
ACTActavis-1.08-0.36%
Data as of 03/03/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$2.31
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account